VISEN PHARMA-B 02561Hong Kong Stock Exchange

18.6101.06%( -0.200 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
VISEN PHARMA-B (02561) Company Profile - Company Info, Industry & Management - cibo

Company Information

Company Name
VISEN Pharmaceuticals
Market
HKEX Main Board
Listing Date
2025-03-21
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
KYG93Y5D1039

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)193.49K112/112
Net Profit (Last FY)-297.18M94/125
ROE (Last FY)-33.26%91/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
卢安邦 Executive Director
付山 Non-Executive Director
曹弋博 Non-Executive Director
Roy Paul KHOURY Non-Executive Director
Sherrie Lynn GLASS Non-Executive Director
Michael J. CHANG Non-Executive Director
陈炳钧 Independent Non-Executive Director
倪虹 Independent Non-Executive Director
张勍 Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-08-27.

About this page

This page shows VISEN PHARMA-B (02561) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.